[go: up one dir, main page]

WO2002061074A1 - Nouvelle proteine et adn la comprenant - Google Patents

Nouvelle proteine et adn la comprenant Download PDF

Info

Publication number
WO2002061074A1
WO2002061074A1 PCT/JP2002/000636 JP0200636W WO02061074A1 WO 2002061074 A1 WO2002061074 A1 WO 2002061074A1 JP 0200636 W JP0200636 W JP 0200636W WO 02061074 A1 WO02061074 A1 WO 02061074A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
activity
inhibiting
screening
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/000636
Other languages
English (en)
Japanese (ja)
Inventor
Atsushi Nakanishi
Yoji Sagiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of WO2002061074A1 publication Critical patent/WO2002061074A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur une nouvelle protéine ayant une activité de canal à fonction neurotransmettrice, sur un ADN codant cette protéine, sur un procédé de criblage d'un composé favorisant ou inhibant l'activité de cette protéine, sur des composés obtenus par le procédé de criblage, etc. L'invention porte notamment sur une protéine ayant une séquence amino-acide identique ou pratiquement identique à la séquence amino-acide représentée par le NO ID SEQ : 1. L'invention porte aussi sur un procédé et un kit de criblage d'un composé favorisant ou inhibant l'activité de cette protéine ; sur des composés favorisant ou inhibant l'activité de la protéine précitée, etc.
PCT/JP2002/000636 2001-01-30 2002-01-29 Nouvelle proteine et adn la comprenant Ceased WO2002061074A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001-22505 2001-01-30
JP2001022505 2001-01-30
JP2001-390239 2001-12-21
JP2001390239 2001-12-21

Publications (1)

Publication Number Publication Date
WO2002061074A1 true WO2002061074A1 (fr) 2002-08-08

Family

ID=26608580

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/000636 Ceased WO2002061074A1 (fr) 2001-01-30 2002-01-29 Nouvelle proteine et adn la comprenant

Country Status (1)

Country Link
WO (1) WO2002061074A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009633A1 (fr) * 2002-07-19 2004-01-29 Inpharmatica Limited Recepteur de serotonine
WO2005073251A1 (fr) * 2004-01-28 2005-08-11 Inpharmatica Limited Recepteur de la serotonine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073431A2 (fr) * 1999-05-27 2000-12-07 Pharmacia & Upjohn Company Techniques et compositions permettant de mesurer la conductance du canal ionique
WO2001068849A2 (fr) * 2000-03-10 2001-09-20 Pharmacia & Upjohn Company Canaux ioniques humains

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073431A2 (fr) * 1999-05-27 2000-12-07 Pharmacia & Upjohn Company Techniques et compositions permettant de mesurer la conductance du canal ionique
WO2001068849A2 (fr) * 2000-03-10 2001-09-20 Pharmacia & Upjohn Company Canaux ioniques humains

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BOULTER, J. ET AL.: "Alpha3, alpha5 and beta4: three members of the rat neutral nicotinic acetylcholine receptor-related gene family form a gene cluster", J. BIOL. CHEM., vol. 265, no. 8, 1990, pages 4472 - 4482, XP002950795 *
DATABASE GENBANK [online] 18 April 1997 (1997-04-18), ADAMS, M.D. ET AL.: "EST16750 aorta endothelial cells, TNF alpha-treated homo sapiens cDNA 5' end, mRNA sequence", XP002950794, Database accession no. (AA304052) *
DATABASE GENBANK [online] 27 January 1997 (1997-01-27), HILLER, L. ET AL.: "Zq69b05. sl", Database accession no. (AA205715) *
DAVIES, P.A. ET AL.: "The 5-HT(3B) subunit is a major determinant of serotonin-receptor function", NATURE, vol. 397, no. 28, 1999, pages 359 - 363, XP002935591 *
HILLER, L. ET AL.: "A generation and analysis of 280,000 human expressed sequence tags", GENOME RES., vol. 6, no. 9, 1996, pages 807 - 828, XP002140684 *
MIYAKE, A. ET AL.: "Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species", MOL. PHARMACOL., vol. 48, 1995, pages 407 - 416, XP001041842 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009633A1 (fr) * 2002-07-19 2004-01-29 Inpharmatica Limited Recepteur de serotonine
WO2005073251A1 (fr) * 2004-01-28 2005-08-11 Inpharmatica Limited Recepteur de la serotonine

Similar Documents

Publication Publication Date Title
WO2003078613A3 (fr) Serine hydroxymethyltransferase en tant que cible d'herbicides
IL210454A0 (en) Novel cytokine zcytor17 ligand
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO2001079465A3 (fr) Acides nucleiques codant pour des polypeptides presentant une activite haloperoxydase
AU2003211952A1 (en) Novel screening method
WO2002084286A1 (fr) Procede de criblage
WO2001055178A3 (fr) Compositions et methodes de traitement de cancer
WO2004082629A3 (fr) Nouvelles cyclosporines
WO2003022868A3 (fr) Proteines pouvant se lier avec des metaux et procedes associes
WO2006032697A3 (fr) Parvovirus
WO2002061074A1 (fr) Nouvelle proteine et adn la comprenant
WO2002101055A3 (fr) Procede de preparation d'acide d-pantothenique et/ou de sels de celui-ci
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
WO2003021262A1 (fr) Procede de criblage
EP1365023A4 (fr) Adn codant une nouvelle d-aminoacylase et procede pour produire un d-aminoacide au moyen de cet adn
DE602004016006D1 (de) Screening-verfahren
WO2003060516A1 (fr) Methode de criblage
WO2003022300A1 (fr) Remedes prophylactiques et curatifs contre les maladies des os et des articulations
WO2002083727A3 (fr) Sequences d'acides nucleiques relatives a des hyperplasies et tumeurs de la glande thyroide
WO2005047513A3 (fr) Complexe de la glycine decarboxylase comme cible herbicide
WO2003038105A3 (fr) Sequences
WO2003021263A1 (fr) Utilisation d'une proteine de recepteur couple a une proteine g
DE602004022857D1 (de) 2-methyl-6-solanylbenzochinon-methyltransferase als ziel für herbizide
WO2003004678A3 (fr) Nouveaux recepteurs
WO2003029290A1 (fr) Transporteur de medicament et son utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10257042

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP